会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 오용 방지 극미립자 경구 약학 제형
    • 抗微生物口服药物形式
    • KR1020080064905A
    • 2008-07-09
    • KR1020087013970
    • 2006-05-24
    • 플라멜 테크놀로지스
    • 귐베르또플로랑스다르글라프레데릭
    • A61K9/58A61K31/785A61K31/343A61P25/04
    • A61K9/5078A61K9/5047
    • The present invention relates to solid microparticulate oral pharmaceutical forms which have a composition and a structure that prevents the misuse of the active pharmaceutical ingredient (API) contained therein. The aim of the present invention is to prevent the improper use of solid oral drugs for any use other than the therapeutic use(s) officially approved by the appropriate public health authorities. In other words, it is a question of preventing the voluntary or involuntary misuse of solid oral drugs. The invention relates to a solid oral pharmaceutical form, characterized in that it comprises anti-misuse means, in that at least part of the API that it contains is contained in coated microparticles for modified API release, and in that the coated API microparticles comprise a coating layer (Ra), which ensures modified release of the API and which, simultaneously, confers resistance to crushing on the coated API microparticles, so as to prevent misuse.
    • 本发明涉及具有防止滥用其中所含的活性药物成分(API)的组成和结构的固体微粒口服药物形式。 本发明的目的是防止不适当地使用固体口服药物用于由适当的公共卫生当局正式批准的治疗用途以外的任何用途。 换句话说,这是一个防止自愿或非自愿滥用固体口服药物的问题。 本发明涉及一种固体口服药物形式,其特征在于其包含抗滥用手段,因为其含有的至少一部分API包含在用于改性API释放的涂覆微粒中,并且涂覆的API微粒包含 涂层(Ra),其确保API的改进释放,并且同时赋予对被涂覆的API微粒的破碎的抵抗力,以防止误用。
    • 4. 发明授权
    • 홍삼 또는 인삼정분을 함유하는 구형의 미세캡슐 제조방법
    • 홍삼또는인삼정분을함유하하는구형의미세캡슐제조방홍삼
    • KR100466719B1
    • 2005-01-17
    • KR1020020006318
    • 2002-02-04
    • (주)케비젠주식회사 일화
    • 김동명박세호신홍식박시호
    • A61K9/58
    • PURPOSE: Provided is a method for preparing the spherical microcapsule of the red ginseng or ginseng extract powders which is stable to the chemical reaction and non-irritative, and conceals the bitter taste of the red ginseng or ginseng by coating the red ginseng or ginseng extract powders with at least one of water soluble polymers. CONSTITUTION: The method for preparing the spherical microcapsule of the red ginseng or ginseng extract powders comprises a step for warming the solution obtained by adding sugar, water soluble starch or hydrophilic polymer to the purified water and then drying it to form the particulate solid state core seeds; a step for coating the core seeds with the red ginseng or ginseng extract powders to form the particulate of 500 to 800 micrometers, thereby preparing the rapid release type spherical microcapsule; a step for coating the rapid release type spherical microcapsule with the polymer coating solution in an amount of 20 to 40 % by total weight of coating film composition of a delayed release type spherical microcapsule to form the delayed release type spherical microcapsule of 1000 to 1200 micrometers; a step for hardening and drying the coating film of the delayed release type spherical microcapsule to a moisture content of 1 to 10 % by total weight of the coating film capsule composition; and a step for meshing the dried microcapsule to 1000 to 1200 micrometers.
    • 目的:提供一种制备红参或人参提取物粉末的球形微胶囊的方法,该球形微胶囊对化学反应和非刺激性是稳定的,并通过涂覆红参或人参提取物来掩盖红参或人参的苦味 粉末与至少一种水溶性聚合物。 构成:制备红参或人参提取物粉末的球形微胶囊的方法包括将通过加入糖,水溶性淀粉或亲水性聚合物得到的溶液加热到纯化水中,然后干燥以形成颗粒状固体核的步骤 种子; 用红参或人参提取物粉末包覆核心种子以形成500-800微米的颗粒,由此制备快速释放型球形微囊; 以延迟释放型球状微胶囊的涂膜组合物的总重量为20至40%的量涂覆快速释放型球状微胶囊以形成1000至1200微米的缓释型球状微胶囊的步骤 ; 将所述延迟释放型球形微胶囊的涂膜硬化并干燥至所述涂膜胶囊组合物的总重量的1至10%的水分含量的步骤; 以及将干燥的微胶囊啮合至1000至1200微米的步骤。
    • 10. 发明公开
    • 수분 감응성 피브리드즈 조성물 및 그 제조방법
    • 水分敏感纤维素组合物及其制备方法
    • KR1020090027838A
    • 2009-03-18
    • KR1020070092949
    • 2007-09-13
    • (주)블루젠
    • 조진원김병규손태원염정현김영훈김태종
    • A61K9/70A61K9/58A61K8/97
    • A61K8/97A61K9/7007
    • A moisture sensitive fibrid is provided to promote healing of wound, to decrease pain due to wound and to prevent severe scar from being generated. A moisture sensitive fibrid comprises synthetic high polymer 0.01-20 weight% forming the moisture sensitive fibrid, natural product polymer 0.01-55 weight% and skin friendship nature biomass 1-10 weight%. The synthetic high polymer forming the moisture sensitive fibrid is one or two or greater selected from a group consisting of polyvinyl pyrridone(PVP), polyvinyl alcohol(PVA), polyethelyeneglycol(PEG), polyethylene oxide(PEO), polyvinyl acrylic acid(PVAc) and polymethacrylic acid(PMAc). The natural polymer forming the moisture sensitive fibrid is two or more natural polymer materials selected from glucomannan, guar gum, locust bean gum, pluronic, algin, elastine, proteoglycan, PLA, PGA, PLGA, xanthan, gellan, collagen, gelatin, agar, carrageenan, alginate, chitosan, chitosan derivation, starch pullulan, galacto.
    • 提供湿敏性纤维蛋白以促进伤口愈合,减少伤口引起的疼痛并防止产生严重的瘢痕。 水分敏感的纤维蛋白包含0.01-20重量%的合成高聚物,形成水分敏感性纤维蛋白,天然产物聚合物0.01-55重量%和皮肤友好性质生物质1-10重量%。 形成水分敏感性纤维蛋白的合成高分子是选自聚乙烯基吡啶酮(PVP),聚乙烯醇(PVA),聚乙二醇(PEG),聚环氧乙烷(PEO),聚乙烯基丙烯酸(PVAc))中的一种或两种以上, 和聚甲基丙烯酸(PMAc)。 形成水分敏感性纤维蛋白的天然聚合物是选自葡甘露聚糖,瓜尔胶,刺槐豆胶,普鲁尼酮,藻酸,弹性蛋白,蛋白聚糖,PLA,PGA,PLGA,黄原胶,结冷胶,胶原,明胶,琼脂中的两种或更多种天然高分子材料, 角叉菜胶,藻酸盐,壳聚糖,壳聚糖衍生物,淀粉支链淀粉,半乳糖。